Thomas F. Hany
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Thomas F. Hany has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Gustav K Von Schulthess
Department of Medical Radiology, Division of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland
4 shared publications- Cyrill Burger
Department of Nuclear Medicine, University Hospital, PET Center, 8091 Zürich, Switzerland
3 shared publications Gustav K. von Schulthess
3 shared publicationsAlfred Buck
2 shared publications- Alfred Buck
University Hospital Zürich
2 shared publications Alexander V Konstantinidis
1 shared publication
Latest Publications
- 1 March 2008
- Vol. 89, 438
Imaging and PET-PET/CT imaging.
PET-CT has grown because the lack of anatomic landmarks in PET makes "hardware-fusion" to anatomic cross-sectional data extremely useful. Addition of CT to PET improves specificity, but also sensitivity, and adding PET to CT adds sensitivity and specificity in tumor imaging. The synergistic advantage of adding CT is that the attenuation correction needed for PET data can also be derived from the CT data. This makes PET-CT 25-30% faster than PET alone, leading to higher patient throughput and a more comfortable examination for patients typically lasting 20 minutes or less. FDG-PET-CT appears to provide relevant information in the staging and therapy monitoring of many tumors, such as lung carcinoma, colorectal cancer, lymphoma, gynaecological cancers, melanoma and many others, with the notable exception of prostatic cancer. For this cancer, choline derivatives may possibly become useful radiopharmaceuticals. The published literature on the applications of FDG-PET-CT in oncology is still limited but several well-designed studies have demonstrated the benefits of PET-CT.
- 1 March 2008
- Vol. 89, 438
Imaging and PET-PET/CT imaging.
PET-CT has grown because the lack of anatomic landmarks in PET makes "hardware-fusion" to anatomic cross-sectional data extremely useful. Addition of CT to PET improves specificity, but also sensitivity, and adding PET to CT adds sensitivity and specificity in tumor imaging. The synergistic advantage of adding CT is that the attenuation correction needed for PET data can also be derived from the CT data. This makes PET-CT 25-30% faster than PET alone, leading to higher patient throughput and a more comfortable examination for patients typically lasting 20 minutes or less. FDG-PET-CT appears to provide relevant information in the staging and therapy monitoring of many tumors, such as lung carcinoma, colorectal cancer, lymphoma, gynaecological cancers, melanoma and many others, with the notable exception of prostatic cancer. For this cancer, choline derivatives may possibly become useful radiopharmaceuticals. The published literature on the applications of FDG-PET-CT in oncology is still limited but several well-designed studies have demonstrated the benefits of PET-CT.
- Open Access
- 31 December 2004
- Published by Springer Nature
- No. 49,p. 85-98
PET/CT: Combining Function and Morphology
- 31 December 2004
- Published by Springer Nature
- No. 49,p. 85-98
Open AccessPET/CT: Combining Function and Morphology
- 1 April 2004
- Vol. 45 (4) , 537-42
CT attenuation correction for myocardial perfusion quantification using a PET/CT hybrid scanner.
In routine PET, a 10- to 20-min transmission scan with a rotating (68)Ge source is commonly obtained for attenuation correction (AC). AC is time-consuming using this procedure and could considerably be shortened by instead using a rapid CT scan. Our aim was to evaluate the feasibility of CT AC in quantitative myocardial perfusion PET using a hybrid PET/CT scanner. (13)N-labeled NH(3) and PET were used to measure myocardial blood flow (MBF) (mL/min/g) at rest and during standard adenosine stress. In group 1 (n = 7), CT scans (0.5 s) of the heart area with different tube currents (10, 40, 80, and 120 mA) were compared with a standard (68)Ge transmission (20 min) and with no AC. In group 2 (n = 3), the repeatability of 8 consecutive CT scans at a tube current of 10 mA was assessed. In group 3 (n = 4), emission was preceded and followed by 3 CT scans (10 mA) and 1 (68)Ge scan for each patient. For reconstruction, filtered backprojection (FBP) was compared with iterative reconstruction (IT). For group 1, no significant difference in mean MBF for resting and hyperemic scans was found when emission reconstructed with (68)Ge AC was compared with emission reconstructed with CT AC at any of the different tube currents. Only emission without any correction differed significantly from (68)Ge AC. For group 2, repeated measurements revealed a coefficient of variance ranging from 2% to 5% and from 2% to 6% at rest and at stress, respectively. For group 3, similar reproducibility coefficients (RC) for MBF were obtained when (68)Ge AC(FBP) was compared with (68)Ge AC(IT) (RC = 0.218) and when CT AC(FBP) was compared with CT AC(IT) (RC = 0.227). Even better reproducibility (lower RC) was found when (68)Ge AC(FBP) was compared with CT AC(FBP) (RC = 0.130) and when (68)Ge AC(IT) was compared with CT AC(IT) (RC = 0.146). Our study shows that for the assessment of qualitative and quantitative MBF with a hybrid PET/CT scanner, the use of CT AC (with a tube current of 10 mA) instead of (68)Ge AC provides accurate results.
- 1 April 2004
- Vol. 45 (4) , 537-42
CT attenuation correction for myocardial perfusion quantification using a PET/CT hybrid scanner.
In routine PET, a 10- to 20-min transmission scan with a rotating (68)Ge source is commonly obtained for attenuation correction (AC). AC is time-consuming using this procedure and could considerably be shortened by instead using a rapid CT scan. Our aim was to evaluate the feasibility of CT AC in quantitative myocardial perfusion PET using a hybrid PET/CT scanner. (13)N-labeled NH(3) and PET were used to measure myocardial blood flow (MBF) (mL/min/g) at rest and during standard adenosine stress. In group 1 (n = 7), CT scans (0.5 s) of the heart area with different tube currents (10, 40, 80, and 120 mA) were compared with a standard (68)Ge transmission (20 min) and with no AC. In group 2 (n = 3), the repeatability of 8 consecutive CT scans at a tube current of 10 mA was assessed. In group 3 (n = 4), emission was preceded and followed by 3 CT scans (10 mA) and 1 (68)Ge scan for each patient. For reconstruction, filtered backprojection (FBP) was compared with iterative reconstruction (IT). For group 1, no significant difference in mean MBF for resting and hyperemic scans was found when emission reconstructed with (68)Ge AC was compared with emission reconstructed with CT AC at any of the different tube currents. Only emission without any correction differed significantly from (68)Ge AC. For group 2, repeated measurements revealed a coefficient of variance ranging from 2% to 5% and from 2% to 6% at rest and at stress, respectively. For group 3, similar reproducibility coefficients (RC) for MBF were obtained when (68)Ge AC(FBP) was compared with (68)Ge AC(IT) (RC = 0.218) and when CT AC(FBP) was compared with CT AC(IT) (RC = 0.227). Even better reproducibility (lower RC) was found when (68)Ge AC(FBP) was compared with CT AC(FBP) (RC = 0.130) and when (68)Ge AC(IT) was compared with CT AC(IT) (RC = 0.146). Our study shows that for the assessment of qualitative and quantitative MBF with a hybrid PET/CT scanner, the use of CT AC (with a tube current of 10 mA) instead of (68)Ge AC provides accurate results.
- 1 May 2003
- Vol. 44 (5) , 732-8
Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies.
CT images represent essentially noiseless maps of photon attenuation at a range of 40-140 keV. Current dual-modality PET/CT scanners transform them into attenuation coefficients at 511 keV and use these for PET attenuation correction. The proportional scaling algorithms hereby used account for the different properties of soft tissue and bone but are not prepared to handle material with other attenuation characteristics, such as oral CT contrast agents. As a consequence, CT-based attenuation correction in the presence of an oral contrast agent results in erroneous PET standardized uptake values (SUVs). The present study assessed these errors with phantom measurements and patient data. Two oral CT contrast agents were imaged at 3 different concentrations in dual-modality CT and PET transmission studies to investigate their attenuation properties. The SUV error due to the presence of contrast agent in CT-based attenuation correction was estimated in 10 patients with gastrointestinal tumors as follows. The PET data were attenuation corrected on the basis of the original contrast-enhanced CT images, resulting in PET images with distorted SUVs. A second reconstruction used modified CT images wherein the CT numbers representing contrast agent had been replaced by CT values producing approximately the right PET attenuation coefficients. These CT values had been derived from the data of 10 patients imaged without a CT contrast agent. The SUV error, defined as the difference between both sets of SUV images, was evaluated in regions with oral CT contrast agent, in tumor, and in reference tissue. The oral CT contrast agents studied increased the attenuation for 511-keV photons minimally, even at the highest concentrations found in the patients. For a CT value of 500 Hounsfield units, the proportional scaling algorithm therefore overestimated the PET attenuation coefficient by 26.2%. The resulting SUV error in the patient studies was highest in regions containing CT contrast agent (4.4% +/- 2.8%; maximum, 11.3%), whereas 1.2% +/- 1.1% (maximum, 4.1%) was found in tumors, and 0.6% +/- 0.7% was found in the reference. The use of oral contrast agents in CT has only a small effect on the SUV, and this small effect does not appear to be medically significant.
- 1 May 2003
- Vol. 44 (5) , 732-8
Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies.
CT images represent essentially noiseless maps of photon attenuation at a range of 40-140 keV. Current dual-modality PET/CT scanners transform them into attenuation coefficients at 511 keV and use these for PET attenuation correction. The proportional scaling algorithms hereby used account for the different properties of soft tissue and bone but are not prepared to handle material with other attenuation characteristics, such as oral CT contrast agents. As a consequence, CT-based attenuation correction in the presence of an oral contrast agent results in erroneous PET standardized uptake values (SUVs). The present study assessed these errors with phantom measurements and patient data. Two oral CT contrast agents were imaged at 3 different concentrations in dual-modality CT and PET transmission studies to investigate their attenuation properties. The SUV error due to the presence of contrast agent in CT-based attenuation correction was estimated in 10 patients with gastrointestinal tumors as follows. The PET data were attenuation corrected on the basis of the original contrast-enhanced CT images, resulting in PET images with distorted SUVs. A second reconstruction used modified CT images wherein the CT numbers representing contrast agent had been replaced by CT values producing approximately the right PET attenuation coefficients. These CT values had been derived from the data of 10 patients imaged without a CT contrast agent. The SUV error, defined as the difference between both sets of SUV images, was evaluated in regions with oral CT contrast agent, in tumor, and in reference tissue. The oral CT contrast agents studied increased the attenuation for 511-keV photons minimally, even at the highest concentrations found in the patients. For a CT value of 500 Hounsfield units, the proportional scaling algorithm therefore overestimated the PET attenuation coefficient by 26.2%. The resulting SUV error in the patient studies was highest in regions containing CT contrast agent (4.4% +/- 2.8%; maximum, 11.3%), whereas 1.2% +/- 1.1% (maximum, 4.1%) was found in tumors, and 0.6% +/- 0.7% was found in the reference. The use of oral contrast agents in CT has only a small effect on the SUV, and this small effect does not appear to be medically significant.
- 1 November 2002
- Vol. 43 (11) , 1469-75
Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system.
The purpose of this study was to evaluate the accuracy of image coregistration of PET and CT (PET/CT) images in patients with lung lesions and the influence of the breathing protocol during CT. Seventy-five patients with a solitary and well-circumscribed pulmonary lesion (non-small cell lung cancer; size, 10-30 mm) underwent PET/CT on a combined scanner. CT was acquired during shallow breathing in 37 patients and during normal expiration (i.e., the level reached when the patient exhaled without forcing expiration and then held the breath) in 38 patients. The volume of interest of each lesion was defined separately on PET and CT images, and the geometric center of gravity (COG) was assessed. The distance of COGs between the PET image and the CT image was measured. All lesions were classified according to 4 lung regions: apical, peripheral, central, and lung base. The mismatch between COG(PET) and COG(CT) was compared between regions and patient groups using a 2-way ANOVA with the Bonferroni-Dunn test for post hoc comparisons. The range of COG distance between PET and CT was 1.7-5.4 mm in the apex, 0.5-14.7 mm in the periphery, 0.7-5.9 mm centrally, and 2.9-11.3 mm in the lung base. The match between PET and CT was significantly better in patients who had the CT scan obtained during normal expiration than in patients who performed shallow breathing during CT scanning (P = 0.024). No reciprocal effects were found (interaction P = 0.76). The mismatch of lesions depends significantly on lung region (P < 0.0001). Post hoc analysis showed a significant difference between the upper 2 regions and the lower 2 regions (all P < or = 0.002) but not between the apex and the central region (P = 0.95) and between the peripheral region and the lung base (P = 0.15). The lesion size had no influence on the COG mismatch. The match of lung lesions in coregistered PET/CT images is better when acquiring the CT scan during normal expiration. The coregistration accuracy is better in the upper and central parts of the lung. The normal expiration protocol is suggested to be superior to shallow breathing during CT scanning.
- 1 November 2002
- Vol. 43 (11) , 1469-75
Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system.
The purpose of this study was to evaluate the accuracy of image coregistration of PET and CT (PET/CT) images in patients with lung lesions and the influence of the breathing protocol during CT. Seventy-five patients with a solitary and well-circumscribed pulmonary lesion (non-small cell lung cancer; size, 10-30 mm) underwent PET/CT on a combined scanner. CT was acquired during shallow breathing in 37 patients and during normal expiration (i.e., the level reached when the patient exhaled without forcing expiration and then held the breath) in 38 patients. The volume of interest of each lesion was defined separately on PET and CT images, and the geometric center of gravity (COG) was assessed. The distance of COGs between the PET image and the CT image was measured. All lesions were classified according to 4 lung regions: apical, peripheral, central, and lung base. The mismatch between COG(PET) and COG(CT) was compared between regions and patient groups using a 2-way ANOVA with the Bonferroni-Dunn test for post hoc comparisons. The range of COG distance between PET and CT was 1.7-5.4 mm in the apex, 0.5-14.7 mm in the periphery, 0.7-5.9 mm centrally, and 2.9-11.3 mm in the lung base. The match between PET and CT was significantly better in patients who had the CT scan obtained during normal expiration than in patients who performed shallow breathing during CT scanning (P = 0.024). No reciprocal effects were found (interaction P = 0.76). The mismatch of lesions depends significantly on lung region (P < 0.0001). Post hoc analysis showed a significant difference between the upper 2 regions and the lower 2 regions (all P < or = 0.002) but not between the apex and the central region (P = 0.95) and between the peripheral region and the lung base (P = 0.15). The lesion size had no influence on the COG mismatch. The match of lung lesions in coregistered PET/CT images is better when acquiring the CT scan during normal expiration. The coregistration accuracy is better in the upper and central parts of the lung. The normal expiration protocol is suggested to be superior to shallow breathing during CT scanning.
- 1 November 2002
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 225 (2) , 575-581
PET Diagnostic Accuracy: Improvement with In-Line PET-CT System: Initial Results
The authors describe the initial application for tumor staging with an in-line system with a positron emission tomographic (PET) scanner and a multi-detector row helical computed tomographic (CT) scanner combined in one machine. Fifty-three patients underwent imaging with four CT tube currents and PET emission and transmission data acquisition. Stepwise analysis of coregistered images revealed a significant (P <.05, McNemar test) improvement in lesion classification between PET images alone and coregistered images from the PET-CT examination.
- 1 November 2002
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 225 (2) , 575-581
PET Diagnostic Accuracy: Improvement with In-Line PET-CT System: Initial Results
The authors describe the initial application for tumor staging with an in-line system with a positron emission tomographic (PET) scanner and a multi-detector row helical computed tomographic (CT) scanner combined in one machine. Fifty-three patients underwent imaging with four CT tube currents and PET emission and transmission data acquisition. Stepwise analysis of coregistered images revealed a significant (P <.05, McNemar test) improvement in lesion classification between PET images alone and coregistered images from the PET-CT examination.
- Top Cited Papers
- 8 August 2002
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 29 (10) , 1393-1398
Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region
Increased symmetrical fluorine-18 fluorodeoxyglucose (FDG) uptake in the cervical and thoracic spine region is well known and has been attributed to muscular uptake. The purpose of this study was to re-evaluate this FDG uptake pattern by means of co-registered positron emission tomography (PET) and computed tomography (CT) imaging, which allowed exact localisation of this uptake. Between April and November 2001, 638 consecutive patients referred for PET/CT were imaged on an in-line PET/CT system (GEMS). This system combines an advanced GE PET scanner and a multirow-detector computer tomograph (Lightspeed, GEMS). The examination included PET with FDG and one CT acquisition with 80 mA. For CT, the following parameters were used: 140 kV, 80 mA, reconstructed slice thickness 5 mm, scan length 867 mm, AT 22.5 s. CT data were used for attenuation correction as well as image co-registration. Image analysis was performed on an Entegra work-station (ELGEMS). All patients with symmetrical uptake within the neck, thorax and shoulder regions were selected and the exact localisation of uptake determined (muscle, bone, fatty tissue or articulation). In 17 of the 638 patients (2.5%), increased, symmetrical FDG uptake in the shoulder region in a typical pattern was found. If extensive, this pattern included FDG activity comparable to brain activity in the lower cervical spine, the shoulder region and the upper thoracic spine in the costovertebral region. A less extensive pattern only involved intermediate FDG uptake in the lower cervical spine and shoulder region or in the shoulder region alone. In seven female patients (average 32.3 years), the extensive uptake pattern was seen. The average body mass index (BMI) was 19.0 (range 16.8–23.4). In the other ten patients (two male, eight female, average age 37.1 years), the average BMI was 22.7 (18.7–27.7). In all patients, the soft tissue uptake was clearly localised within the fatty tissue of the shoulders as demonstrated by PET/CT co-registration. The uptake in the region of the thoracic spine was localised in the region of the costovertebral joints. Symmetrical FDG uptake in the shoulder, neck and thoracic spine region is probably related to uptake in adipose tissue, especially in underweight patients. Hypothetically, this FDG uptake could represent activated brown adipose tissue during increased sympathetic nerve system (SNS) activity due to cold stress.
- 8 August 2002
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 29 (10) , 1393-1398
Top Cited PapersBrown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region
Increased symmetrical fluorine-18 fluorodeoxyglucose (FDG) uptake in the cervical and thoracic spine region is well known and has been attributed to muscular uptake. The purpose of this study was to re-evaluate this FDG uptake pattern by means of co-registered positron emission tomography (PET) and computed tomography (CT) imaging, which allowed exact localisation of this uptake. Between April and November 2001, 638 consecutive patients referred for PET/CT were imaged on an in-line PET/CT system (GEMS). This system combines an advanced GE PET scanner and a multirow-detector computer tomograph (Lightspeed, GEMS). The examination included PET with FDG and one CT acquisition with 80 mA. For CT, the following parameters were used: 140 kV, 80 mA, reconstructed slice thickness 5 mm, scan length 867 mm, AT 22.5 s. CT data were used for attenuation correction as well as image co-registration. Image analysis was performed on an Entegra work-station (ELGEMS). All patients with symmetrical uptake within the neck, thorax and shoulder regions were selected and the exact localisation of uptake determined (muscle, bone, fatty tissue or articulation). In 17 of the 638 patients (2.5%), increased, symmetrical FDG uptake in the shoulder region in a typical pattern was found. If extensive, this pattern included FDG activity comparable to brain activity in the lower cervical spine, the shoulder region and the upper thoracic spine in the costovertebral region. A less extensive pattern only involved intermediate FDG uptake in the lower cervical spine and shoulder region or in the shoulder region alone. In seven female patients (average 32.3 years), the extensive uptake pattern was seen. The average body mass index (BMI) was 19.0 (range 16.8–23.4). In the other ten patients (two male, eight female, average age 37.1 years), the average BMI was 22.7 (18.7–27.7). In all patients, the soft tissue uptake was clearly localised within the fatty tissue of the shoulders as demonstrated by PET/CT co-registration. The uptake in the region of the thoracic spine was localised in the region of the costovertebral joints. Symmetrical FDG uptake in the shoulder, neck and thoracic spine region is probably related to uptake in adipose tissue, especially in underweight patients. Hypothetically, this FDG uptake could represent activated brown adipose tissue during increased sympathetic nerve system (SNS) activity due to cold stress.
- 1 August 2002
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 179 (2) , 477-481
Application of Oral Contrast Media in Coregistered Positron Emission Tomography—CT
OBJECTIVE. Coregistration of positron emission tomography (PET) and CT images results in significantly improved localization of abnormal FDG uptake compared with PET images alone. For delineation of intestinal structures, application of oral contrast media is a standard procedure in CT. The influence of oral contrast agents in PET imaging using CT data for attenuation correction was evaluated in a comparative study on an in-line PET—CT system. SUBJECTS AND METHODS. Sixty patients referred for PET—CT were evaluated in two groups. One group of 30 patients received oral Gastrografin 45 min before data acquisition. The second group received no contrast medium. PET images were reconstructed, using CT data for attenuation correction. Image analysis was performed by two reviewers in consensus, using a 4-point scale comparing FDG-uptake in the gastrointestinal tract in PET images of both groups. Furthermore, correlation of FDG uptake and localization of contrast media in the intestinal tract in CT images were determined. RESULTS. No significant difference in FDG uptake in PET images in all regions of the gastrointestinal tract except the ascending colon was seen in both groups. No correlation was found in the location of increased FDG uptake and contrast media in the CT images. CONCLUSION. An oral contrast agent can be used for coregistered PET—CT without the introduction of artifacts in PET.
- 1 August 2002
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 179 (2) , 477-481
Application of Oral Contrast Media in Coregistered Positron Emission Tomography—CT
OBJECTIVE. Coregistration of positron emission tomography (PET) and CT images results in significantly improved localization of abnormal FDG uptake compared with PET images alone. For delineation of intestinal structures, application of oral contrast media is a standard procedure in CT. The influence of oral contrast agents in PET imaging using CT data for attenuation correction was evaluated in a comparative study on an in-line PET—CT system. SUBJECTS AND METHODS. Sixty patients referred for PET—CT were evaluated in two groups. One group of 30 patients received oral Gastrografin 45 min before data acquisition. The second group received no contrast medium. PET images were reconstructed, using CT data for attenuation correction. Image analysis was performed by two reviewers in consensus, using a 4-point scale comparing FDG-uptake in the gastrointestinal tract in PET images of both groups. Furthermore, correlation of FDG uptake and localization of contrast media in the intestinal tract in CT images were determined. RESULTS. No significant difference in FDG uptake in PET images in all regions of the gastrointestinal tract except the ascending colon was seen in both groups. No correlation was found in the location of increased FDG uptake and contrast media in the CT images. CONCLUSION. An oral contrast agent can be used for coregistered PET—CT without the introduction of artifacts in PET.